Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03548285 · OUTCOME

Number of Patients With Local Failure Following SABR Treatment of Early Glottic Larynx Cancers

Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer · Source last updated 2025-05-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
2 years

What was measured

Local failure is defined as biopsy-proven tumor anywhere on the true vocal cords.

Groups in this outcome

All Patients

All patients on the clinical trial.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients25

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
description
Local failure is defined as biopsy-proven tumor anywhere on the true vocal cords.
groups
  1. description
    All patients on the clinical trial.
    id
    OG000
    title
    All Patients
param Type
NUMBER
reporting Status
POSTED
time Frame
2 years
title
Number of Patients With Local Failure Following SABR Treatment of Early Glottic Larynx Cancers
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice